Literature DB >> 16176902

Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium.

Qing Huang1, Li-Jun Wu, Shin-Ichi Tashiro, Satoshi Onodera, Lin-Hao Li, Takashi Ikejima.   

Abstract

Silymarin was proved to have a protective effect of UV-induced A375-S2 cell apoptosis in our previous research. In this study, its pro-apoptotic and anti-apoptotic activities on human cervical cancer (HeLa) cells in vitro were investigated. Silymarin induced HeLa cell death through both apoptotic and necrotic pathways. At low doses (below 80 micromol l-1), it induced cell apoptosis, but caused necrosis at high dose (160 micromol l-1). Silymarin induced typical chromatin condensation and nuclear fragmentation as a hallmark of apoptosis. In this case, mitochondrial Bcl-2 family, Bcl-2 and Bax, were not involved in apoptotic effects; however, silymarin-induced cell death was regulated by the activation of p38 and JNK MAPKs. We also found that pan-caspase inhibitor and caspase-3 inhibitor could not antagonise silymarin-induced apoptosis. Therefore, silymarin induced and augmented HeLa cell apoptosis through p38/JNK MAPKs in the serum-free medium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176902     DOI: 10.1080/1028602042000324862

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  7 in total

1.  Silymarin mitigates lung impairments in a rat model of acute respiratory distress syndrome.

Authors:  Zhongming Zhu; Gengyun Sun
Journal:  Inflammopharmacology       Date:  2017-11-02       Impact factor: 4.473

2.  Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells.

Authors:  Sung-Hyun Kim; Gang-Sik Choo; Eun-Seon Yoo; Joong-Seok Woo; So-Hee Han; Jae-Han Lee; Ji-Youn Jung
Journal:  Oncol Rep       Date:  2019-08-28       Impact factor: 3.906

3.  Silymarin inhibits Toll-like receptor 8 gene expression and apoptosis in Ramos cancer cell line.

Authors:  Nasrin Ranjbar; Ramin Saravani; Zohreh Faezizadeh
Journal:  Avicenna J Phytomed       Date:  2020 Mar-Apr

4.  Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis.

Authors:  Sung-Hyun Kim; Gang-Sik Choo; Eun-Seon Yoo; Joong-Seok Woo; Jae-Han Lee; So-Hee Han; Soo-Hyun Jung; Hyeong-Jin Kim; Ji-Youn Jung
Journal:  Oncol Lett       Date:  2021-04-26       Impact factor: 2.967

Review 5.  Mechanistic Insights into the Pharmacological Significance of Silymarin.

Authors:  Karan Wadhwa; Rakesh Pahwa; Manish Kumar; Shobhit Kumar; Prabodh Chander Sharma; Govind Singh; Ravinder Verma; Vineet Mittal; Inderbir Singh; Deepak Kaushik; Philippe Jeandet
Journal:  Molecules       Date:  2022-08-21       Impact factor: 4.927

Review 6.  Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer.

Authors:  Hun Soon Jung; Nirmal Rajasekaran; Woong Ju; Young Kee Shin
Journal:  J Clin Med       Date:  2015-05-21       Impact factor: 4.241

7.  HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targetting miR-23b/MAPK1 axis.

Authors:  Qin Li; Yanhong Feng; Xu Chao; Shuai Shi; Man Liang; Yumei Qiao; Bin Wang; Pin Wang; Zhenning Zhu
Journal:  Biosci Rep       Date:  2018-02-08       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.